Motilin receptor neuropharmacology: Revised understanding

Current Opinion in Pharmacology

Volumn 12, Issue 6, 2012, Pages 641-646

  Sanger, Gareth J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAMICINAL; ERYTHROMYCIN; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MOTILIN; MOTILIN RECEPTOR; TZP 201; UNCLASSIFIED DRUG;

ARTICLE; DIARRHEA; DIET RESTRICTION; DOSE RESPONSE; DRUG MECHANISM; FOOD INTAKE; GASTROINTESTINAL TRACT; HORMONE ACTION; HORMONE RELEASE; HUMAN; LOW DRUG DOSE; MIGRATING MOTOR COMPLEX; MOTOR SYSTEM; MUSCLE CELL; NEUROMUSCULAR SYSTEM; NEUROPHARMACOLOGY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL;

EID: 84870530977     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.07.012     Document Type: Review

References (49)

1. N.D. Christofides Importance of the jejunal hormone motilin J Clin Path 33 suppl 8 1978 51 57
2. T. Peeters, G. Matthijs, I. Depoortere, T. Cachet, J. Hoogmartens, and G. Vantrappen Erythromycin is a motilin receptor agonist Am J Physiol 257 1989 G470 G474
3. S.D. Feighner, C.P. Tan, K.K. McKee, O.C. Palyha, D.L. Hreniuk, S.-S. Pong, C.P. Austin, D. Figueroa, D. MacNeil, and M.A. Cascieri Receptor for motilin identified in the human gastrointestinal system Science 284 1999 2184 2188
4. H. Nakajima, E. Mochiki, A. Zietlow, K. Ludwig, and T. Takahashi Mechanism of interdigestive migrating motor complex in conscious dogs J Gastroenterol 45 2010 506 514
5. V.B. Nieuwenhuijs, A. Verheem, H. van Duijvenbode-Beumer, M.R. Visser, J. Verhoef, H.G. Gooszen, and L.M. Akkermans The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats Ann Surg 228 1998 188 193
6. D.C. Ang, H. Nicolai, R. Vos, P.V. Berghe, D. Sifrim, I. Depoortere, T.L. Peeters, J. Janssens, and J.F. Tack Hunger scores correlate with the occurrence of pharmacologically induced gastric phase 3 in man Gastroenterology 134 suppl 1 2008 A-285
7. D.C. Ang, H. Nicolai, R. Vos, P.V. Berghe, D. Sifrim, I. Depoortere, T.L. Peeters, J. Janssens, and J.F. Tack Gastric phase 3 is a hunger signal in the interdigestive state in man Gastroenterology 134 suppl 1 2008 A-314
8. K.Y. Lee, T.M. Chang, and W.Y. Chey Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in fasting dog Am J Physiol 245 1983 G547 G553
9. H. Thomas, C. Chen, and E. Marsault The motilin receptor antagonist TZP-201 is highly effective in the control of irinotecan induced diarrhea in beagle dogs Neurogastroenterol Motil 19 suppl 3 2007 35
10. J. Broad, S. Mukherjee, M. Samadi, J.E. Martin, G.E. Dukes, and G.J. Sanger Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists Br J Pharmacol 2012 10.1111/j.1476-5381.2012.02009.x
11. M. Simren, E.S. Bjornsson, and H. Abrahamsson High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome Neurogastroenterol Motil 17 2005 51 57
12. J. He, D.M. Irwin, R. Chen, and Y. Zhang Stepwise loss of motilin and its specific receptor genes in rodents J Mol Endocrinol 44 2010 37 44
13. G.J. Sanger, J.D. Holbrook, and P.L.R. Andrews The translational value of rodent gastrointestinal functions: a cautionary tale Trends Pharmacol Sci 32 2011 402 409
14. A. Bassil, C. Murray, N.M. Dass, A. Muir, and G.J. Sanger Prokineticin-2, motilin, ghrelin and metoclopramide: prokinetic utility in mouse stomach and colon Eur J Pharmacol 524 2005 138 144
15. E. Takeshita, B. Matsuura, M. Dong, L.J. Miller, H. Matsui, and M. Onji Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract J Gastroenterol 41 2006 223 230
16. W.P. Ter Beek, E.S.M. Möller, M. van den Berg, M.J. Meijer, I. Biemond, and C.B. Lamers Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine Inflamm Bowel Dis 14 2008 612 619
17. E. Mochiki, A. Inui, M. Satoh, A. Mizumoto, and Z. Itoh Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs Am J Physiol 272 1997 G224 G232
18. H. Suzuki, E. Mochika, N. Haga, M. Satoh, A. Mizumoto, and Z. Itoh Motilin controls cyclic release of insulin through vagal cholinergic muscarinic pathways in fasted dogs Am J Physiol 274 1998 G87 G95
19. N. Inatomi, F. Sato, S. Marui, Z. Itoh, and S. Omura Vagus-dependent and vagus-independent mechanisms of action of the erythromycin derivative EM574 and motilin in dogs Jap J Pharmacol 71 1996 29 38
20. A.M. Zietlow, K.A. Ludwig, and T. Takahashi Association between plasma ghrelin and motilin levels during MMC cycle in conscious dogs Reg Peptides 164 2010 78 82
21. B. Coulie, J. Tack, T. Peeters, and J. Janssens Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans Gut 43 1998 395 400
22. M.A. Boivin, M.C. Carey, and H. Levy Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects Pharmacotherapy 23 2003 5 8
23. R. Cuomo, P. Vandaele, B. Coulie, T. Peeters, I. Depoortere, J. Janssens, and J. Tack Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways Am J Gastroenterol 101 2006 804 811
24. N.B. Dass, J. Hill, A. Muir, T. Testa, A. Wise, and G.J. Sanger The rabbit motilin receptor: molecular characterisation and pharmacology Br J Pharmacol 140 2003 948 954
25. E.M. Jarvie, V.J. North Laidler, S. Corcoran, A. Bassil, and G.J. Sanger Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro Br J Pharmacol 150 2007 455 462
26. G.E. Dukes, M. Barton, O. Dewit, K. Stephens, L. Vasist, M. Young, D. Richards, D. Alpers, and P. Williams Safety/tolerability, pharmacokinetics (PK), and effect on gastric emptying(GE) with 14-days repeat oral dosing of the motilin receptor agonist, GSK962040, in healthy male and female volunteers Neurogastroenterol Motil 22 S1 2010 14 15
27. L. Thielemans, I. Depoortere, J. Perret, P. Robberecht, Y. Liu, T. Thijs, C. Carreras, E. Burgeon, and T.L. Peeters Desensitization of the human motilin receptor by motilides J Pharmacol Exp Ther 313 2005 1397 1405
28. G.J. Sanger Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases Drug Discovery Today 13 2008 234 239
29. S.M. Westaway, and G.J. Sanger The identification and rationale for drugs which act at the motilin receptor Prog Med Chem 48 2009 31 80
30. V. Lamian, A. Rich, Z. Ma, J. Li, R. Seethala, D. Gordon, and Y. Dubaquie Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis Mol Pharmacol 69 2006 109 118
31. R. Dhir, and J.E. Richter Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis J Clin Gastroenterol 38 2004 237 242
32. B. Matsuura, M. Dong, S. Naik, L.J. Miller, and M. Onji Differential contributions of motilin receptor extracellular domains for peptide and non-peptidyl agonist binding and activity J Biol Chem 281 2006 12390 12396
33. J. Tack, and T. Peeters What comes after macrolides and other motilin stimulants? Gut 49 2001 317 318
34. M. Camilleri Motilin agonists and dyspepsia: throwing out the baby with the bath water Gut 51 2002 612
35. J.J. Li, H.-G. Chao, H. Wang, J.A. Tino, R.M. Lawrence, W.R. Ewing, Z. Ma, M. Yan, D. Slusarchyk, R. Seethala, and H. Sun Discovery of a potent and novel motilin agonist J Med Chem 47 2004 1704 1708
36. G.J. Sanger, S.M. Westaway, A.A. Barnes, D.T. MacPherson, A.I. Muir, E.M. Jarvie, V. Bolton, S. Cellek, E. Näslund, P.M. Hellström, and R.A. Borman GSK962040A: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility Neurogastroenterol Motil 21 2009 657 666
37. M. Camilleri, A. Papathanasopoulos, and S.T. Odunsi Action and therapeutic pathways of ghrelin for gastrointestinal disorders Nat Rev Gastroenterol Hepatol 6 2009 343 352
38. N. Wierup, M. Björkqvist, B. Weström, S. Pierzynowski, F. Sundler, and K. Sjölund Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine J Clin Endocrinol Metab 92 2007 3573 3581
39. S. Gnanapavan, B. Bustin, D.G. Morris, P. McGee, P. Fairclough, S. Bhattacharya, R. Carpenter, A.B. Grossman, and M. Korbonits The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R in humans J Clin Endocrinol Metab 87 2002 2988 2991
40. H. Nunoi, B. Matsuura, S. Utsunomiya, T. Ueda, T. Miyake, S. Furukawa, T. Kumagi, Y. Ikeda, M. Abe, Y. Hiasa, and M. Onji A relationship between motilin and growth hormone secretagogue receptors Reg Peptides 176 2012 28 35
41. L. Xu, S. Gao, F. Guo, and X. Sun Effect of motilin on gastric distension sensitive neurons in arcuate nucleus and gastric motility in rat Neurogastroenterol Motil 23 2011 265 270
42. J.J. Maguire, R.E. Kuc, and A.P. Davenport Motilin mediates vasoconstriction in human coronary artery in vitro Proc Br Pharmacol Soc 2004 At http://www.pa2online.org/Vol2Issue2abst116P.hyml
43. N.Q. Nguyen, A.A. Mangoni, R.J. Fraser, M. Chapman, L. Brtyant, C. Burgstad, and R.H. Holloway Prokinetic therapy with erythromycin has no significant impact on blood pressure and heart rate in critically ill patients Br J Clin Pharmacol 63 2006 498 500
44. A.A. Mangoni, J.C. Close, S. Rodriguez, R.A. Sherwood, C.A. Bryant, C.G. Swift, and S.H. Jackson Acute hypotensive effects of oral cisapride and erythromycin in healthy subjects Br J Clin Pharmacol 58 2004 223 224
45. Y. Higuchi, J. Nishimura, and H. Kanaide Motilin induces the endothelium-dependent relaxation of smooth muscle and the elevation of cytosolic calcium in endothelial cells in situ Biochem Biophys Res Commun 202 1994 346 353
46. T. Iwai, H. Nakamura, H. Takanashi, K. Yogo, K. Ozaki, N. Ishizuka, and T. Asano Hypotensive mechanism of [Leu13]motilin in dogs in vivo and in vitro Can J Physiol Pharmacol 76 1998 1103 1109
47. W.A. Ray, K.T. Murray, S. Meredith, S.S. Narasimhulu, K. Hall, and C.M. Stein Oral erythromycin and the risk of sudden death from cardiac causes N Engl J Med 351 2004 1089 1096
48. T. Wisialowski, K. Crimin, J. Engtrakul, J. O'Donnell, B. Fermini, and A.A. Fossa Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability J Pharmacol Exp Ther 318 2006 352 359
49. S. Leming, J. Broad, S.J. Cozens, M. Otterson, W. Winchester, K. Lee, G.E. Dukes, and G.J. Sanger GSK962040: a small molecule motilin receptor agonist which increases gastrointestinal motility in conscious dogs Neurogastroenterol Motil 23 2011 958 964